Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuster, V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fuster, V.

(Circulation. 1998;97:715.)
© 1998 American Heart Association, Inc.


In Memoriam

Richard Gorlin, MD

The Passing of a Legend and a Mentor

Valentin Fuster, MD, PhD, New York, NY

Dr Richard Gorlin, one of the preeminent cardiologists of the latter half of the 20th century, died on October 16, 1997, at age 71 years, of pancreatic cancer. Until the last days of his illness, Dr Gorlin continued to work as a physician, to serve as Medical Director of the Mount Sinai Health System, and to inspire those around him.

Dr Gorlin's contributions to cardiovascular medicine are legendary and have immensely influenced the clinical care of patients with valvular heart disease, coronary artery disease, and congestive heart failure. He earned an international reputation when, in collaboration with his father, a mechanical engineer who designed hydraulic systems for gasoline engines at the beginning of the century, he developed a formula to calculate the area of stenotic cardiac valves and congenital heart chamber defects. The "Gorlin formula," still considered the "gold standard" for diagnosis of critical heart valve obstruction, was crucial to the evolution of cardiac surgery because it allowed proper case selection and contributed greatly to the design of artificial valves.

Dr Gorlin conducted pioneering studies of coronary blood flow and myocardial metabolism in ischemic and hypertrophic heart disease and demonstrated that some areas of the myocardium that appear mechanically quiescent can, when stimulated, exhibit contractile activity. This observation foreshadowed by a decade the concept of "hibernating myocardium." Dr Gorlin was among the first to describe what is now widely recognized as "microvascular angina" in a group of patients without coronary obstruction. He also described "myocardial asynergy" related to coronary artery . . . [Full Text of this Article]